The global Immunohistochemistry Market is valued at an estimated USD 3.4 billion in 2024 and is projected to reach USD 5.2 ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.

From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

The Pakistan Federal Union of Journalists (PFUJ) has filed a petition in the Islamabad High Court challenging the recent amendments to the country's cybercrime law, calling for them to be struck ...

The FDA has approved a companion diagnostic to determine if patients with HR-positive, HER2-ultralow metastatic breast cancer ...

In a move widely seen as "court packing", the federal government has successfully shuffled the deck in the Islamabad High Court (IHC) by transferring three judges from other high courts – a ...

The ChEA3 database was utilized to predict the transcription factors regulated by core ubiquitination-related genes. The expression of select URGs was validated using qRT-PCR and immunohistochemistry ...